Michiels C - Search Results

1

Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies.

Martinive P, Defresne F, Bouzin C, Saliez J, Lair F, Grégoire V, Michiels C, Dessy C, Feron O. Martinive P, et al. Among authors: michiels c. Cancer Res. 2006 Dec 15;66(24):11736-44. doi: 10.1158/0008-5472.CAN-06-2056. Cancer Res. 2006. PMID: 17178869 Free article.

2

Intermittent hypoxia changes HIF-1alpha phosphorylation pattern in endothelial cells: unravelling of a new PKA-dependent regulation of HIF-1alpha.

Toffoli S, Feron O, Raes M, Michiels C. Toffoli S, et al. Among authors: michiels c. Biochim Biophys Acta. 2007 Oct;1773(10):1558-71. doi: 10.1016/j.bbamcr.2007.06.002. Epub 2007 Jun 16. Biochim Biophys Acta. 2007. PMID: 17662481 Free article.

3

Radioimmunotherapy with radioactive nanoparticles: first results of dosimetry for vascularized and necrosed solid tumors.

Bouchat V, Nuttens VE, Lucas S, Michiels C, Masereel B, Féron O, Gallez B, Vander Borght T. Bouchat V, et al. Among authors: michiels c. Med Phys. 2007 Nov;34(11):4504-13. doi: 10.1118/1.2791038. Med Phys. 2007. PMID: 18072516

4

Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression.

Cosse JP, Michiels C. Cosse JP, et al. Among authors: michiels c. Anticancer Agents Med Chem. 2008 Oct;8(7):790-7. doi: 10.2174/187152008785914798. Anticancer Agents Med Chem. 2008. PMID: 18855580 Review.

5

Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1.

Toffoli S, Roegiers A, Feron O, Van Steenbrugge M, Ninane N, Raes M, Michiels C. Toffoli S, et al. Among authors: michiels c. Angiogenesis. 2009;12(1):47-67. doi: 10.1007/s10456-009-9131-y. Epub 2009 Jan 29. Angiogenesis. 2009. PMID: 19184477

6

NDRG1 and CRK-I/II are regulators of endothelial cell migration under Intermittent Hypoxia.

Toffoli S, Delaive E, Dieu M, Feron O, Raes M, Michiels C. Toffoli S, et al. Among authors: michiels c. Angiogenesis. 2009;12(4):339-54. doi: 10.1007/s10456-009-9156-2. Epub 2009 Sep 17. Angiogenesis. 2009. PMID: 19760510

7

Radioimmunotherapy with radioactive nanoparticles: biological doses and treatment efficiency for vascularized tumors with or without a central hypoxic area.

Bouchat V, Nuttens VE, Michiels C, Masereel B, Feron O, Gallez B, Vander Borght T, Lucas S. Bouchat V, et al. Among authors: michiels c. Med Phys. 2010 Apr;37(4):1826-39. doi: 10.1118/1.3368599. Med Phys. 2010. PMID: 20443505

8

Differential influence of anticancer treatments and angiogenesis on the seric titer of autoantibody used as tumor and metastasis biomarker.

Defresne F, Bouzin C, Guilbaud C, Dieu M, Delaive E, Michiels C, Raes M, Feron O. Defresne F, et al. Among authors: michiels c. Neoplasia. 2010 Jul;12(7):562-70. doi: 10.1593/neo.10238. Neoplasia. 2010. PMID: 20651985 Free PMC article.

9

Surface properties and cell adhesion onto allylamine-plasma and amine-plasma coated glass coverslips.

Crespin M, Moreau N, Masereel B, Feron O, Gallez B, Vander Borght T, Michiels C, Lucas S. Crespin M, et al. Among authors: michiels c. J Mater Sci Mater Med. 2011 Mar;22(3):671-82. doi: 10.1007/s10856-011-4245-3. Epub 2011 Feb 3. J Mater Sci Mater Med. 2011. PMID: 21287241

10

Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis.

Végran F, Boidot R, Michiels C, Sonveaux P, Feron O. Végran F, et al. Among authors: michiels c. Cancer Res. 2011 Apr 1;71(7):2550-60. doi: 10.1158/0008-5472.CAN-10-2828. Epub 2011 Feb 7. Cancer Res. 2011. PMID: 21300765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

535 results

Search Page

Filters